To determine if the formation of NETs in SI-ALI was pathogenic, mice were treated with peptidylarginine deiminase type 4 (PAD4) inhibitor (GSK484) to inhibit NETs formation, anti-Ly6G antibody to deplete neutrophils, and DNase I to degrade NETs respectively. This evidence concerns the gene PADI4 and acute respiratory distress syndrome.